Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2

<p>Abstract</p> <p>Background</p> <p>Experimental clinical stem cell therapy has been used for more than a decade to alleviate the adverse aftermath of acute myocardial infarction (aMI). The post-infarcted myocardial microenvironment is characterized by cardiomyocyte de...

Full description

Bibliographic Details
Main Authors: Przybyt Ewa, Krenning Guido, Brinker Marja GL, Harmsen Martin C
Format: Article
Language:English
Published: BMC 2013-02-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://www.translational-medicine.com/content/11/1/39
_version_ 1818155501906558976
author Przybyt Ewa
Krenning Guido
Brinker Marja GL
Harmsen Martin C
author_facet Przybyt Ewa
Krenning Guido
Brinker Marja GL
Harmsen Martin C
author_sort Przybyt Ewa
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Experimental clinical stem cell therapy has been used for more than a decade to alleviate the adverse aftermath of acute myocardial infarction (aMI). The post-infarcted myocardial microenvironment is characterized by cardiomyocyte death, caused by ischemia and inflammation. These conditions may negatively affect administered stem cells. As postnatal cardiomyocytes have a poor proliferation rate, while induction of proliferation seems even more rare. Thus stimulation of their proliferation rate is essential after aMI. In metaplastic disease, the pro-inflammatory cytokine interleukin-6 (IL-6) has been identified as potent mediators of the proliferation rate. We hypothesized that IL-6 could augment the proliferation rate of (slow-)dividing cardiomyocytes.</p> <p>Methods</p> <p>To mimic the behavior of therapeutic cells in the post-infarct cardiac microenvironment, human Adipose Derived Stromal Cells (ADSC) were cultured under hypoxic (2% O<sub>2</sub>) and pro-inflammatory conditions (IL-1β) for 24h. Serum-free conditioned medium from ADSC primed with hypoxia and/or IL-1β was added to rat neonatal cardiomyocytes and adult cardiomyocytes (HL-1) to assess paracrine-driven changes in cardiomyocyte proliferation rate and induction of myogenic signaling pathways.</p> <p>Results</p> <p>We demonstrate that ADSC enhance the proliferation rate of rat neonatal cardiomyocytes and adult HL-1 cardiomyocytes in a paracrine fashion. ADSC under hypoxia and inflammation <it>in vitro</it> had increased the interleukin-6 (IL-6) gene and protein expression. Similar to conditioned medium of ADSC, treatment of rat neonatal cardiomyocytes and HL-1 with recombinant IL-6 alone also stimulated their proliferation rate. This was corroborated by a strong decrease of cardiomyocyte proliferation after addition of IL-6 neutralizing antibody to conditioned medium of ADSC. The stimulatory effect of ADSC conditioned media or IL-6 was accomplished through activation of both Janus Kinase-Signal Transducer and Activator of Transcription (JAK/STAT) and Mitogen-Activated Protein (MAP) kinases (MAPK) mitogenic signaling pathways.</p> <p>Conclusion</p> <p>ADSC are promising therapeutic cells for cardiac stem cell therapy. The inflammatory and hypoxic host post-MI microenvironment enhances the regenerative potential of ADSC to promote the proliferation rate of cardiomyocytes. This was achieved in paracrine manner, which warrants the development of ADSC conditioned medium as an “of-the-shelf” product for treatment of post-myocardial infarction complications.</p>
first_indexed 2024-12-11T14:43:25Z
format Article
id doaj.art-ee0acf77dd6649cba999d106d02e8c17
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-11T14:43:25Z
publishDate 2013-02-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-ee0acf77dd6649cba999d106d02e8c172022-12-22T01:01:49ZengBMCJournal of Translational Medicine1479-58762013-02-011113910.1186/1479-5876-11-39Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2Przybyt EwaKrenning GuidoBrinker Marja GLHarmsen Martin C<p>Abstract</p> <p>Background</p> <p>Experimental clinical stem cell therapy has been used for more than a decade to alleviate the adverse aftermath of acute myocardial infarction (aMI). The post-infarcted myocardial microenvironment is characterized by cardiomyocyte death, caused by ischemia and inflammation. These conditions may negatively affect administered stem cells. As postnatal cardiomyocytes have a poor proliferation rate, while induction of proliferation seems even more rare. Thus stimulation of their proliferation rate is essential after aMI. In metaplastic disease, the pro-inflammatory cytokine interleukin-6 (IL-6) has been identified as potent mediators of the proliferation rate. We hypothesized that IL-6 could augment the proliferation rate of (slow-)dividing cardiomyocytes.</p> <p>Methods</p> <p>To mimic the behavior of therapeutic cells in the post-infarct cardiac microenvironment, human Adipose Derived Stromal Cells (ADSC) were cultured under hypoxic (2% O<sub>2</sub>) and pro-inflammatory conditions (IL-1β) for 24h. Serum-free conditioned medium from ADSC primed with hypoxia and/or IL-1β was added to rat neonatal cardiomyocytes and adult cardiomyocytes (HL-1) to assess paracrine-driven changes in cardiomyocyte proliferation rate and induction of myogenic signaling pathways.</p> <p>Results</p> <p>We demonstrate that ADSC enhance the proliferation rate of rat neonatal cardiomyocytes and adult HL-1 cardiomyocytes in a paracrine fashion. ADSC under hypoxia and inflammation <it>in vitro</it> had increased the interleukin-6 (IL-6) gene and protein expression. Similar to conditioned medium of ADSC, treatment of rat neonatal cardiomyocytes and HL-1 with recombinant IL-6 alone also stimulated their proliferation rate. This was corroborated by a strong decrease of cardiomyocyte proliferation after addition of IL-6 neutralizing antibody to conditioned medium of ADSC. The stimulatory effect of ADSC conditioned media or IL-6 was accomplished through activation of both Janus Kinase-Signal Transducer and Activator of Transcription (JAK/STAT) and Mitogen-Activated Protein (MAP) kinases (MAPK) mitogenic signaling pathways.</p> <p>Conclusion</p> <p>ADSC are promising therapeutic cells for cardiac stem cell therapy. The inflammatory and hypoxic host post-MI microenvironment enhances the regenerative potential of ADSC to promote the proliferation rate of cardiomyocytes. This was achieved in paracrine manner, which warrants the development of ADSC conditioned medium as an “of-the-shelf” product for treatment of post-myocardial infarction complications.</p>http://www.translational-medicine.com/content/11/1/39Myocardial infarctionHypoxiaInflammationADSCInterleukin-6Cardiomyocyte ProliferationSTAT3Erk1/2
spellingShingle Przybyt Ewa
Krenning Guido
Brinker Marja GL
Harmsen Martin C
Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
Journal of Translational Medicine
Myocardial infarction
Hypoxia
Inflammation
ADSC
Interleukin-6
Cardiomyocyte Proliferation
STAT3
Erk1/2
title Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
title_full Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
title_fullStr Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
title_full_unstemmed Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
title_short Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate <it>in vitro</it> through STAT3 and Erk1/2
title_sort adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate it in vitro it through stat3 and erk1 2
topic Myocardial infarction
Hypoxia
Inflammation
ADSC
Interleukin-6
Cardiomyocyte Proliferation
STAT3
Erk1/2
url http://www.translational-medicine.com/content/11/1/39
work_keys_str_mv AT przybytewa adiposestromalcellsprimedwithhypoxiaandinflammationenhancecardiomyocyteproliferationrateitinvitroitthroughstat3anderk12
AT krenningguido adiposestromalcellsprimedwithhypoxiaandinflammationenhancecardiomyocyteproliferationrateitinvitroitthroughstat3anderk12
AT brinkermarjagl adiposestromalcellsprimedwithhypoxiaandinflammationenhancecardiomyocyteproliferationrateitinvitroitthroughstat3anderk12
AT harmsenmartinc adiposestromalcellsprimedwithhypoxiaandinflammationenhancecardiomyocyteproliferationrateitinvitroitthroughstat3anderk12